Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $12.24 USD
Change Today -0.26 / -2.08%
Volume 37.8K
GNCA On Other Exchanges
Symbol
Exchange
NASDAQ GM
Frankfurt
As of 8:10 PM 04/24/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

William D. Clark

Chief Executive Officer, President and Director, Genocea Biosciences, Inc.
AgeTotal Calculated CompensationThis person is connected to 15 board members in 1 different organizations across 3 different industries.

See Board Relationships
45$573,305
As of Fiscal Year 2014

Background*

Mr. William D. Clark, also known as Chip has been the Chief Executive Officer and President at Genocea Biosciences, Inc. since February 2011. Mr. Clark served as the Chief Business Officer at Genocea Biosciences, Inc. since August 2010. Mr. Clark served as the Chief Business Officer, Senior Vice President and Secretary of Vanda Pharmaceuticals, Inc. from September 2004 to March 26, 2010 and co-founded it in 2002. Prior to Vanda, Mr. Clark served a Principal of Care Capital ...

Read Full Background

Corporate Headquarters*

100 Acorn Park Drive
Cambridge, Massachusetts 02140

United States

Phone: 617-876-8191
Fax: --

Board Members Memberships*

2003-2004
Former Chief Business Officer, Senior Vice President and Secretary
2011-Present
Chief Executive Officer, President and Director

Education*

BA
Harvard University
MBA
University of Pennsylvania - The Wharton School

Other Affiliations*

Annual Compensation*

Salary$393,561
Total Annual Compensation$393,561

Stock Options*

Exercisable Options496,781
Unexercisable Options83,775
Total Number of Options620,363

Total Compensation*

Total Annual Cash Compensation$573,305
Total Short Term Compensation$393,561
Total Calculated Compensation$573,305
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GNCA:US $12.24 USD -0.26

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
J. Joseph Kim Ph.D.Chief Executive Officer, President, Director and Member of Finance Committee
Inovio Pharmaceuticals, Inc.
$964.7K
Douglas J. Swirsky CPA, CFAChief Executive Officer, President, Corporate Secretary and Director
GenVec, Inc.
$316.3K
Jeffrey D. Abbey MBA, J.D.Chief Executive Officer, President and Director
Argos Therapeutics, Inc.
$543.6K
Hans Arwidsson Ph.D.Chief Executive Officer and President
Eurocine Vaccines AB
kr1.1M
Daniel J. O'Connor Esq.Chief Executive Officer, President and Director
Advaxis, Inc.
$398.8K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GENOCEA BIOSCIENCES INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.